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groups (A, W-135 and Y), and the importance
given to the risk of capsular switching. As a first
step, the epidemiology of these minority sero-
groups in the various regions of Europe should
be studied in greater detail.
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ABSTRACT
This study examined the ability of PCR to amplify
Leishmania DNA, stored on Giemsa-stained slides,
from American cutaneous leishmaniasis (ACL)
patients. In total, 475 slides stored for up to
36 years were obtained from an outpatient clinic
in a Brazilian ACL-endemic region, and Leish-
mania DNA was amplified from 395 (83.2%) of the
DNA samples using primers specific for the
minicircle kinetoplast DNA. Restriction fragment
length polymorphism analysis of these amplicons
demonstrated that Leishmania (Viannia) braziliensis
was the only species present in these samples. The
results demonstrated that archived Giemsa-
Corresponding author and reprint requests: A. C. Volpini,
Laborato´rio de Pesquisas em Leishmanioses, Departamento de
Imunologia, Pavilha˜o Leoˆnidas Deane, Sala 509, IOC–FIO-
CRUZ, Av. Brazil 4365, Manguinhos, Rio de Janeiro RJ 21040-
360, Brazil
E-mail: avolpini@ioc.fiocruz.br
Research Note 815
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 12, 793–821
stained slides can provide a Leishmania DNA
source for performing clinical and epidemiologi-
cal studies of leishmaniasis.
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At least six species of Leishmania from the subgen-
era Viannia and Leishmania are believed to cause
American cutaneous leishmaniasis (ACL) in Brazil,
where the disease has been recorded in all states
[1,2]. Most severe forms of ACL are caused by
Leishmania (Viannia) braziliensis [3]. Despite low
positivity compared with other techniques [4–7],
direct microscopy of stained lesion tissue imprints
is used for a definitive ACL diagnosis. However,
individual Leishmania spp. can be identified only
after isolation and cultivation.
PCR is an exceptionally sensitive tool for the
detection of target DNA. Using PCR, genetic
investigations can be performed with a broad
range of DNA sources, such as amber-conserved
insects, mummies, slides, blood or semen [8]. A
number of reports have described the use of PCR
for amplifying DNA from Plasmodium [9,10],
Mycobacterium tuberculosis [11], Cryptosporidium
parvum [12] and Leishmania [5–7,13–17]. The pur-
pose of the present study was to investigate whe-
ther extraction and amplification of Leishmania
DNA could be achieved from tissue lesion
imprints on Giemsa-stained slides that had been
stored for up to 36 years. The possible use of
restriction fragment length polymorphism (RFLP)
analysis of the conserved region of the Leishmania
minicircle kinetoplast DNA (mkDNA) [17] for
identification of the Leishmania spp. present on
these slides was also investigated.
In total, 3652 microscope slides positive for
parasites were stored at room temperature for up
to 36 years (1965–2001) at an outpatient clinic in
the Leishmania-endemic region of Vale do Rio
Doce, Minas Gerais, Brazil. In order to ensure an
equal chance for all slides to be selected at a
significance level of 95%, the numbers of slides
selected systematically for study for each of three
periods (Table 1) were 198, 158 and 119, so that, in
total, 475 slides were investigated by PCR.
An area covering two imprints was scraped
from each slide with a toothpick, resuspended in
20 lL of double-distilled water and transferred to
0.5-mL microtubes. Samples were heated at 70C
for 10 min, and then centrifuged at 12 000 g for
5 min at room temperature, after which 2 lL of
the supernatant was used as a DNA template.
Two reference strains of L. (V.) braziliensis and
two of Leishmania (Leishmania) amazonensis were
used as controls for PCR and RFLP patterns. DNA
from these reference strains was extracted from
culture using a Wizard Genomic DNA Purifica-
tion System (Promega, Madison, WI, USA),
following the manufacturer’s instructions. PCR
amplification was performed using Leishmania
mkDNA-specific primers [6]. For the PCR-RFLP
mkDNA analysis, 5 lL of the amplification
products were digested with 1 U of either HaeIII
(Invitrogen, Sa˜o Paulo, Brazil) or ApaLI (Amer-
sham Biosciences, Chalfont St Giles, UK) for 3 h at
37C in the buffer recommended by the product
manufacturer. The fragment patterns have been
described previously [17].
Of 475 slides, 395 (83.2%) yielded positive PCR
results, with a DNA amplicon of 120 bp (Table 1).
The positivity rate ranged from 70.2% to 93.7%
for the three periods, with a mean of 83.2%. HaeIII
and ApaLI cut the 120-bp amplicons from
L. (V.) braziliensis to yield DNA fragments of 80
and 40 bp, and 88 and 32 bp, respectively, but did
not cut amplicons from L. (L.) amazonensis [17].
Amplicons from all PCR-positive samples in the
present study were digested by HaeIII or ApaLI
and demonstrated RFLP profiles identical to those
obtained with DNA from the L. (V.) braziliensis
reference strains (Fig. 1). No RFLP profiles similar
to that of L. (L.) amazonensis were detected among
the PCR-positive samples. For the negative sam-
ples, the presence of DNA on Giemsa-stained
slides was tested with a PCR specific for the
human housekeeping gene gapdh [18]; only
Table 1. Results of Leishmania-specific PCR amplification
from lesion imprints on Giemsa-stained glass slides of
samples from patients with American cutaneous leish-
maniasis collected between 1965 and 2001
Period
Giemsa-stained glass slides
Archived Tested PCR-positive (%)
First: 1965–1976 198 198 139 (70.2)
Second: 1977–1988 973 158 148 (93.7)
Third: 1989–2001 2481 119 108 (90.8)
Total: 1965–2001 3652 475 395 (83.2)
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eight (13.5%) of the 59 Leishmania-negative
samples from the first period were positive for
gapdh.
The results confirmed that Leishmania DNA can
be amplified by PCR from slides archived for up
to 36 years, and indicated that this approach may
be an alternative method for detection and iden-
tification of this parasite. Previous studies with
slides prepared more recently have reported
contrasting results [13,14].
The high percentage (29.8%) of negative results
with slides from the first period may have been
caused by the presence of PCR inhibitors or the
poor state of slide conservation. The possibility of
inhibitors was eliminated by the demonstration of
positive PCR results when purified Leishmania
DNA was added to the DNA sample. The low
number of slides positive by PCR for gapdh (8 ⁄ 59)
suggests that the stored slides from the first
period were indeed poorly conserved.
Only a limited area of each sample was used,
because the collection of archived slides was
unique, and the material had to be assayed and
returned to the collection with minimum damage
to the sample set. The high percentage of Leish-
mania-positive PCR results obtained with slides
from the second and third periods indicates that
the DNA extracted using this simple heating
method from small amounts of tissue was suitable
for amplification, thereby removing the need for
other extraction methods, such as the phenol–
chloroform method [13] or other commercial
procedures.
Using PCR-RFLP analysis of mkDNA [17], it
was possible to confirm previous findings that
L. (V.) braziliensis was the only species causing
ACL in this area [19,20]. Amplicons from 12
samples in the set were sequenced and found to
be identical to the sequences expected for
L. (V.) braziliensis. The high sensitivity and spe-
cificity of PCR-RFLP of mkDNA enabled the
ready detection of Leishmania DNA and species
identification. The PCR-RFLP mkDNA assay
might be a useful epidemiological tool in an
endemic region where leishmaniasis occurs in an
enzootic cycle. The species identified as being
responsible for an outbreak can be compared with
those in previous endemic cases. These data,
together with information concerning geograph-
ical distribution, would be helpful in predicting
future changes in disease transmission, and
should explain whether leishmaniasis is an emer-
ging or a re-emerging disease in a particular
region. The present study also highlighted the
historical value of stored tissue collections for
retrospective studies, which might be useful in
predicting the course of many diseases, thereby
providing a guide to preventive measures that
should be adopted for disease avoidance or
control.
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ABSTRACT
The efficacy of an educational intervention to
prevent blood culture contamination (BCC) in
internal medicine was studied in two medical
wards in a busy tertiary-care hospital in which
blood cultures were obtained by physicians rather
than dedicated phlebotomists. Baseline BCC rates
were 5.7% and 7.1% in intervention and control
wards, respectively (p 0.6), compared with 1.95%
and 6.7%, respectively, post-intervention
(p < 0.001). Following multivariate analysis, only
an absence of intervention was an independent
variable associated with BCC. Thus simple edu-
cational intervention reduced BCC in internal
medicine and was considered to be cost-effective.
Keywords Blood cultures, contamination, disinfec-
tion, education, intervention, prevention
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